At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
PET/CT +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging in Patients Undergoing Selective Internal Radiation Therapy for Hepatic Malignancies
In Brief
A clinical study evaluating PET/CT, PET/MR, and 1 other intervention for Hepatic Malignancies. Completed, enrolled 11 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the results of positron emission tomography/computer tomography (PET/CT) to positron emission tomography/magnetic resonance imaging (PET/MRI) to help determine any added advantage of one over the other in relation to a tumor which might assist in further management plans.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHepatic Malignancies
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartMar 2020
First PostedApr 2020
Primary CompletionSep 2020
TodayJul 2026
First PostedApr 2, 2020
Enrollment StartMar 3, 2020
Primary CompletionSep 21, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 6.3 years ago
Interventions
PET/CTdevice
Standard Imaging
PET/MRdevice
Additional Imaging
SIRT with Y-90radiation
SIRT with Y-90 for palliative treatment of the liver malignancy.